Historical Valuation
Shuttle Pharmaceuticals Holdings Inc (SHPH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Shuttle Pharmaceuticals Holdings Inc (SHPH) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：1.87
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Shuttle Pharmaceuticals Holdings Inc (SHPH) has a current Price-to-Book (P/B) ratio of 1.60. Compared to its 3-year average P/B ratio of 2.03 , the current P/B ratio is approximately -20.96% higher. Relative to its 5-year average P/B ratio of -0.04, the current P/B ratio is about -4451.77% higher. Shuttle Pharmaceuticals Holdings Inc (SHPH) has a Forward Free Cash Flow (FCF) yield of approximately -385.91%. Compared to its 3-year average FCF yield of -171.13%, the current FCF yield is approximately 125.51% lower. Relative to its 5-year average FCF yield of -153.08% , the current FCF yield is about 152.10% lower.
P/B
Median3y
2.03
Median5y
-0.04
FCF Yield
Median3y
-171.13
Median5y
-153.08
Competitors Valuation Multiple
AI Analysis for SHPH
The average P/S ratio for SHPH competitors is 0.03, providing a benchmark for relative valuation. Shuttle Pharmaceuticals Holdings Inc Corp (SHPH.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for SHPH
1Y
3Y
5Y
Market capitalization of SHPH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of SHPH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is SHPH currently overvalued or undervalued?
Shuttle Pharmaceuticals Holdings Inc (SHPH) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Shuttle Pharmaceuticals Holdings Inc (SHPH) is between to according to relative valuation methord.
What is Shuttle Pharmaceuticals Holdings Inc (SHPH) fair value?
SHPH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Shuttle Pharmaceuticals Holdings Inc (SHPH) is between to according to relative valuation methord.
How does SHPH's valuation metrics compare to the industry average?
The average P/S ratio for SHPH's competitors is 0.03, providing a benchmark for relative valuation. Shuttle Pharmaceuticals Holdings Inc Corp (SHPH) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Shuttle Pharmaceuticals Holdings Inc (SHPH) as of Jan 09 2026?
As of Jan 09 2026, Shuttle Pharmaceuticals Holdings Inc (SHPH) has a P/B ratio of 1.60. This indicates that the market values SHPH at 1.60 times its book value.
What is the current FCF Yield for Shuttle Pharmaceuticals Holdings Inc (SHPH) as of Jan 09 2026?
As of Jan 09 2026, Shuttle Pharmaceuticals Holdings Inc (SHPH) has a FCF Yield of -385.91%. This means that for every dollar of Shuttle Pharmaceuticals Holdings Inc’s market capitalization, the company generates -385.91 cents in free cash flow.
What is the current Forward P/E ratio for Shuttle Pharmaceuticals Holdings Inc (SHPH) as of Jan 09 2026?
As of Jan 09 2026, Shuttle Pharmaceuticals Holdings Inc (SHPH) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Shuttle Pharmaceuticals Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Shuttle Pharmaceuticals Holdings Inc (SHPH) as of Jan 09 2026?
As of Jan 09 2026, Shuttle Pharmaceuticals Holdings Inc (SHPH) has a Forward P/S ratio of 0.00. This means the market is valuing SHPH at $0.00 for every dollar of expected revenue over the next 12 months.